P1037: DOES EARLY INTERVENTION IN MYELOFIBROSIS IMPACT OUTCOMES? A POOLED ANALYSIS OF THE COMFORT I AND II STUDIES

• C. Harrison,
• J.-J. Kiladjian,
• A. M. Vannucchi,
• R. A. Mesa,
• R. M. Scherber,
• J. Hamer-Maansson,
• S. Verstovsek

Affiliations

C. Harrison

1 Guy’s and St. Thomas’ NHS Foundation Trust, Guy’s Hospital, London, United Kingdom

J.-J. Kiladjian

2 Hôpital Saint-Louis, Assitance Publique – Hôpitaux de Paris, Université de Paris, Inserm, Paris, France

A. M. Vannucchi

3 CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy

R. A. Mesa

4 Mays Cancer Institute at UT Health San Antonio MD Anderson, San Antonio

R. M. Scherber

5 Incyte Corporation, Wilmington

J. Hamer-Maansson

5 Incyte Corporation, Wilmington

S. Verstovsek

6 The University of Texas MD Anderson Cancer Center, Houston, United States of America